Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 2 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for Nykode Therapeutics ASA have a median target of 19.81, with a high estimate of 49.47 and a low estimate of 9.85. The median estimate represents a 288.41% increase from the last price of 5.10.
High | 870.0% | 49.47 |
Med | 288.4% | 19.81 |
Low | 93.2% | 9.85 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 27, 2024.
Average growth rate | -11.79% |
Average growth rate | -194.26% |
More ▼
Revenue history & estimates in USD
Average growth rate | -39.57% |
Average growth rate | -27.23% |
More ▼